Background: A guideline is provided for the implementation of regional deep hyperthermia treatments under strict rules of quality assurance. The objective is to guarantee a comparable and comprehensible method in the treatment and scientific analysis of hyperthermia. The guideline describes regional deep hyperthermia (RHT) and MR-controlled partial body hyperthermia (PBH) of children, young and adult patients. According to this guideline, hyperthermia treatment is always applied in combination with chemotherapy and/or radiotherapy. Methods: The guideline is based on practical experience from several hyperthermia centers. The procedure allows applying jointly coordinated standards and quality control in hyperthermia for studies. Results: The guideline contains recommendations for hyperthermia treatments, including indication, preparation, treatment, and standardized analysis.

, , , , ,
doi.org/10.1007/s00066-011-1145-x, hdl.handle.net/1765/33623
Strahlentherapie und Onkologie
Erasmus MC: University Medical Center Rotterdam

Bruggmoser, G., Bauchowitz, S., Canters, R., Crezee, H., Ehmann, M., Gellermann, J., … van Rhoon, G. (2011). Quality assurance for clinical studies in regional deep hyperthermia. Strahlentherapie und Onkologie, 187(10), 605–610. doi:10.1007/s00066-011-1145-x